Riskpilot← Back to searchSign inGet full accessMirantum AB
ABActiveOrg 5591032965Björnsbacken 8Physiotherapy activities · NACE 8695Est. 20170 employees
Revenue 2025
SEK 174K
+29% vs 2024
EBITDA margin
66.7%
+142% vs 2024
Equity ratio
94.9%
Financial strength
Net profit 2025
SEK 100K
+122% vs 2024
| Revenue | SEK 174K | +29% |
| EBITDA | SEK 116K | +142% |
| Net profit | SEK 100K | +122% |
| Total assets | SEK 667K | +21% |
| Equity | SEK 633K | +19% |
| Employees | 0 | — |
Legal name
Mirantum AB
Org number
5591032965
Legal form
Aktiebolag
NACE code
8695 · Physiotherapy activities
Founded
3 mars 2017
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-09-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget ska i Sverige och utomlands bedriva - handel med och förvaltning av värdepapper för egen räkning, - konsultverksamhet avseende företagsorganisation, hälso- och sjukvård samt fiskeguidning.
Address
Björnsbacken 8
Email
staffan.le.bergstrom@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 90 | 161 | 107 | 135 | 174 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 16 | 103 | 22 | 48 | 116 |
| Depreciation & amort. | −3 | −3 | −1 | −1 | −3 |
| EBIT | 13 | 100 | 21 | 47 | 113 |
| Net financials | — | — | — | 10 | 14 |
| Profit before tax | 13 | 100 | 21 | 57 | 126 |
| Tax | −3 | −21 | −4 | −12 | −26 |
| Net profit | 10 | 79 | 17 | 45 | 100 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 400 | 497 | 510 | 553 | 667 |
| Equity | 391 | 470 | 488 | 533 | 633 |
| Long-term debt | 20 | 20 | 20 | 20 | 20 |
| Short-term debt | 11 | 7 | 2 | 0 | 14 |
| Total debt | 31 | 27 | 22 | 20 | 34 |
EBITDA margin
66.7%
This company
15.8%
Market median
+322% vs market
20212025
Equity ratio
94.9%
This company
38.2%
Market median
+148% vs market
20212025
Return on equity
15.8%
This company
18.4%
Market median
+14% vs market
20212025
Net profit margin
57.5%
This company
8.1%
Market median
+610% vs market
20212025
Asset turnover
0.26×
This company
1.12×
Market median
-77% vs market
20212025
Debt / equity
0.05×
This company
0.62×
Market median
+92% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-10-01 – 2025-09-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-10-01 – 2024-09-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-10-01 – 2023-09-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-10-01 – 2022-09-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-10-01 – 2021-09-30
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Mirantum AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Albin Immanuel Bergström | Deputy Board Member | 0 companies |
| Lars Erik Staffan Bergström | Board of Directors | 0 companies |